Avoid pregabalin during pregnancy: TGA

“Risk of major congenital malformations” prescribers warned as drug moved to pregnancy Category D The Therapeutic Goods Administration (TGA) has strengthened its warnings around epilepsy and pain drug pregabalin for it not to be prescribed to pregnant women because of the potential for “major congenital malformations” to the foetus. The latest warning, which changes the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Blaze guts town’s only pharmacy
Next COVID booster reignites pay parity calls